Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1168877

	registered interest
	date	06/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Care Homes: Learning Disability
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many (a) unexpected deaths and (b) serious injuries have occurred in residential care homes among people with learning difficulties in each year since 2010.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	432
	answer	answer is ministerial correction date of answer 09/01/2020 answer text <p>The following table shows Unexpected Death and Serious Injury Notifications raised against 'Residential social care home' locations with a Service User Band of 'Learning disabilities or autistic spectrum disorder', from 1 April 2010, provided by the Care Quality Commission:</p><table><tbody><tr><td><p> </p></td><td colspan="2"><p>Number of Notifications</p></td></tr><tr><td><p>Raised Year</p></td><td><p>16-1 Unexpected Death</p></td><td><p>18-2a,b Serious Injury</p></td></tr><tr><td><p>2010</p></td><td><p>260</p></td><td><p>558</p></td></tr><tr><td><p>2011</p></td><td><p>1,201</p></td><td><p>2,656</p></td></tr><tr><td><p>2012</p></td><td><p>1,248</p></td><td><p>3,112</p></td></tr><tr><td><p>2013</p></td><td><p>936</p></td><td><p>3,077</p></td></tr><tr><td><p>2014</p></td><td><p>948</p></td><td><p>3,215</p></td></tr><tr><td><p>2015</p></td><td><p>1,067</p></td><td><p>3,866</p></td></tr><tr><td><p>2016</p></td><td><p>1,221</p></td><td><p>4,236</p></td></tr><tr><td><p>2017</p></td><td><p>1,081</p></td><td><p>4,573</p></td></tr><tr><td><p>2018</p></td><td><p>1,153</p></td><td><p>4,513</p></td></tr><tr><td><p>2019</p></td><td><p>959</p></td><td><p>4,812</p></td></tr><tr><td><p>2020</p></td><td><p>12</p></td><td><p>48</p></td></tr><tr><td><p>Grand Total</p></td><td><p>10,086</p></td><td><p>34,666</p></td></tr></tbody></table><p> </p><p>Notes:</p><ol><li>The data does not indicate whether a notification relates directly to someone with a learning disability or autism, only that the location has the Service User Band of 'Learning disabilities or autistic spectrum disorder'. A location may have more than one Service User Band.</li><li>'Residential social care home' locations are defined as locations with a Primary Inspection Category of 'Residential social care', or with an Organisation Type of 'Social Care Organisation' and any of the Service Types 'Care home services with nursing', 'Care home services without nursing' or 'Specialist college services'</li><li>This data is at location level only.</li><li>The data for 2010 reflects both an incomplete year of reporting, i.e. from 1 April<ins class="ministerial"> 2010</ins><del class="ministerial">, and</del> from a starting point of data from <del class="ministerial">the</del> National Health Service <ins class="ministerial">providers </ins>alone<ins class="ministerial">,</ins> before <ins class="ministerial">social care and independent healthcare </ins>providers across <del class="ministerial">the United Kingdom</del> <ins class="ministerial">England </ins>were included.</li><li>Data for 2020 is up to and including 7 January.</li></ol><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 09/01/2020 12:17:38 question first ministerially corrected 20/01/2020 16:11:31 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 388 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4523 label Biography information for Catherine West

1002110

	registered interest
	date	05/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Prisons
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many prisons have (a) healthcare and (b) drug rehabilitation and care services provided by private healthcare providers.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	188189
	answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>This information is not available in the format requested.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 188190 question first answered 12/11/2018 15:45:17 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4523 label Biography information for Catherine West

1002111

	registered interest
	date	05/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Prisons
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many prisons have (a) healthcare and (b) drug rehabilitation and care services provided by NHS healthcare providers.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	188190
	answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>This information is not available in the format requested.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 188189 question first answered 12/11/2018 15:45:17 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4523 label Biography information for Catherine West

1005714

	registered interest
	date	12/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sapropterin
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to NHS England’s appraisal of Kuvan, what steps his Department is taking to ensure that the cost offset of dietary treatments is considered in its economic assessment of the cost of commissioning new medicines.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	190518
	answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>NHS England has considered a policy for Kuvan (sapropterin) at the Clinical Priorities Advisory Group (CPAG) meeting on 6/7 November. Whilst NHS England did make an estimate of the current cost of protein supplements and a potential reduction in their use if Kuvan were prescribed, this cost was not included in the analysis because commissioning responsibility for supplements rests with clinical commissioning groups and it would be unlikely that NHS England would be able to realise these savings. The cost of the potential reduction in protein supplements is also relatively modest compared to the cost of Kuvan.</p><p> </p><p>In line with its published process, the recommendations from CPAG will be considered by the Specialised Commissioning Oversight Group and the Specialised Services Commissioning Committee. A decision about whether or not Kuvan has been prioritised for funding will be published in due course.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is currently developing technology appraisal guidance for the National Health Service on the use of Kuvan for the treatment of phenylketonuria. In developing technology appraisal guidance, NICE takes into account all the health and publicly funded social care related costs and benefits associated with the treatment, potentially including any costs from NHS funded treatments that can be avoided such as food supplements. The NICE appraisal of Kuvan is now underway and NICE expects to publish final guidance next year.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 190519 question first answered 20/11/2018 15:25:36 answering member 4067 label Biography information for Steve Brine
	tabling member	4523 label Biography information for Catherine West

1005715

	registered interest
	date	12/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sapropterin
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the financial cost offset to the NHS including savings to the NHS from reduced acquisition costs of food supplements of commissioning Kuvan for the treatment of phenylketonuria.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	190519
	answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>NHS England has considered a policy for Kuvan (sapropterin) at the Clinical Priorities Advisory Group (CPAG) meeting on 6/7 November. Whilst NHS England did make an estimate of the current cost of protein supplements and a potential reduction in their use if Kuvan were prescribed, this cost was not included in the analysis because commissioning responsibility for supplements rests with clinical commissioning groups and it would be unlikely that NHS England would be able to realise these savings. The cost of the potential reduction in protein supplements is also relatively modest compared to the cost of Kuvan.</p><p> </p><p>In line with its published process, the recommendations from CPAG will be considered by the Specialised Commissioning Oversight Group and the Specialised Services Commissioning Committee. A decision about whether or not Kuvan has been prioritised for funding will be published in due course.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is currently developing technology appraisal guidance for the National Health Service on the use of Kuvan for the treatment of phenylketonuria. In developing technology appraisal guidance, NICE takes into account all the health and publicly funded social care related costs and benefits associated with the treatment, potentially including any costs from NHS funded treatments that can be avoided such as food supplements. The NICE appraisal of Kuvan is now underway and NICE expects to publish final guidance next year.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 190518 question first answered 20/11/2018 15:25:36 answering member 4067 label Biography information for Steve Brine
	tabling member	4523 label Biography information for Catherine West

1005716

	registered interest
	date	12/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Rare Diseases: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether a single technology appraisal process or a highly specialised technology appraisal process is used for (a) phenylketonuria and (b) other rare diseases.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	190520
	answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>Medicines and other treatments being considered for assessment by the National Institute for Health and Care Excellence (NICE) are considered through an established topic selection process to ensure that they are suitable for referral to NICE and that they are routed to the most appropriate process within NICE. The topic selection process includes consideration of topic against published criteria and consultation with stakeholders. Most new medicines are referred for assessment through NICE’s technology appraisal programme though NICE also operates a separate highly specialised technology evaluation programme for a small number of very high cost drugs for the treatment of very rare diseases. Following consideration through the topic selection process, NICE is currently developing guidance on two drugs for the treatment of phenylketonuria through its technology appraisal programme.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/11/2018 15:26:35 answering member 4067 label Biography information for Steve Brine
	tabling member	4523 label Biography information for Catherine West

1023015

	registered interest
	date	10/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood: Contamination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what resources have been allocated to the NHS Business Services Authority to support victims of the contaminated blood scandal.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	200720
	answer	answer is ministerial correction date of answer 17/12/2018 answer text <p>In 2018/19, NHS Business Services Authority has been awarded an annual budget allocation of up to £46.3 million from the Department to provide support for those affected by infected blood.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 17/12/2018 14:53:32 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4523 label Biography information for Catherine West

1023898

	registered interest
	date	12/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood: Contamination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what types of support the NHS Business Services Authority provides to victims and family members of those affected by the contaminated blood scandal; and whether that support includes (a) bookable appointments, (b) face-to-face support and (c) telephone support.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	201686
	answer	answer is ministerial correction date of answer 18/12/2018 answer text <p>Information on support available to beneficiaries of the England Infected Blood Support Scheme (EIBSS), administered by NHS Business Services Authority, is available on the EIBSS website at the following link:</p><p> </p><p><a href="https://www.nhsbsa.nhs.uk/england-infected-blood-support-scheme" target="_blank">https://www.nhsbsa.nhs.uk/england-infected-blood-support-scheme</a></p><p> </p><p>EIBSS does not provide beneficiaries with bookable appointments or face to face support. However, beneficiaries can obtain advice from the EIBSS’ telephone service where information on all support available can be obtained.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 18/12/2018 14:08:49 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4523 label Biography information for Catherine West

1041410

	registered interest
	date	14/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Public Bodies
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many staff at (a) Care Quality Commission, (b) Health Education England, (c) Health Research Authority, (d) Medicines and Healthcare Products Regulatory Agency and (e) NHS England that work (i) inside and (ii) outside Greater London are paid at a rate below the London Living Wage.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	208377
	answer	answer is ministerial correction date of answer 22/01/2019 answer text <p>The Care Quality Commission (CQC), Health Education England (HEE), the Health Research Authority, the Medicines and Healthcare products Regulatory Agency (MHRA) and NHS England comply with minimum wage legislation and pay all directly employed staff at levels at or above the National Living Wage.</p><p> </p><p>All London employees of the CQC, HEE, the HRA, the MHRA and NHS England earn the London Living Wage.</p><p> </p><p>The CQC has 290 employees outside London earning less than the London Living Wage.</p><p>HEE has 229 employees outside London earning less than the London Living Wage.</p><p>The HRA has 21 employees outside London earning less than the London Living Wage.</p><p>The MHRA has three employees outside London earning less than the London Living Wage.</p><p>NHS England has 282 employees outside London earning less than the London Living Wage.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 22/01/2019 15:33:34 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4523 label Biography information for Catherine West

1041411

	registered interest
	date	14/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Public Bodies
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many staff at (a) Care Quality Commission, (b) Health Education England, (c) Health Research Authority, (d) Medicines and Healthcare Products Regulatory Agency and (e) NHS England that work (i) inside and (ii) outside Greater London are paid at a rate below the Real Living Wage.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	208378
	answer	answer is ministerial correction date of answer 22/01/2019 answer text <p>The Care Quality Commission (CQC), Health Education England (HEE), the Health Research Authority, the Medicines and Healthcare products Regulatory Agency (MHRA) and NHS England comply with minimum wage legislation and pay all directly employed staff at levels at or above the National Living Wage.</p><p> </p><p>The CQC, HEE, the HRA, the MHRA and NHS England have no staff in London who earn below the Real Living Wage.</p><p> </p><p>The CQC has 73 employees earning below the Real Living Wage outside of London.</p><p>HEE has 0 employees earning below the Real Living Wage outside of London.</p><p>The HRA has 0 employees earning below the Real Living Wage outside of London.</p><p>The MHRA has 0 employees earning below the Real Living Wage outside of London.</p><p>NHS England has five employees earning below the Real Living Wage outside of London.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 22/01/2019 15:32:19 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4523 label Biography information for Catherine West